NeuroTech recently announced the successful completion of the first clinical trial for its domestically developed, fully implantable, wireless, and multifunctional brain-computer interface (BCI) product. The trial, conducted by a team led by Professors Mao Ying and Chen Liang at Huashan Hospital affiliated with Fudan University, enabled a patient with eight years of complete paralysis below the shoulders to control digital devices—such as cursors, web browsing, and gaming—through thought alone. The system also seamlessly integrates with physical devices like pneumatic gloves, smart wheelchairs, smart home systems, and even humanoid robots.
The product features a fully implanted design, including a built-in battery, eliminating all external cables and significantly reducing infection risks associated with traditional exposed systems. Innovatively, the battery module is placed subcutaneously in the chest, building upon and refining the established deep brain stimulation (DBS) framework while keeping heat-generating components away from the brain for long-term safety.
Additionally, the device integrates wireless power and data transmission, freeing patients from external hardware. Post-surgery, users can engage in real-time thought-based interactions without wearing or connecting any external equipment.
Clinical outcomes showed rapid recovery: the patient was transferred to a general ward within a day post-operation and achieved successful mind-controlled operations just five days later, demonstrating smooth web navigation, precise clicks, and video playback. With training, the patient’s brain-controlled decoding speed reached 5.2 bits per second (BPS), matching top international standards.
Comments